These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 7816348

  • 1. Effects of bifemelane on parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset.
    Nomoto M, Irifune M, Fukuzaki K, Fukuda T.
    Neurosci Lett; 1994 Aug 29; 178(1):95-8. PubMed ID: 7816348
    [Abstract] [Full Text] [Related]

  • 2. Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP.
    Rose S, Nomoto M, Kelly E, Kilpatrick G, Jenner P, Marsden CD.
    Neurosci Lett; 1989 Jul 03; 101(3):305-10. PubMed ID: 2505199
    [Abstract] [Full Text] [Related]

  • 3. MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.
    Schneider JS.
    J Neurosci Res; 1992 Jan 03; 31(1):112-9. PubMed ID: 1613817
    [Abstract] [Full Text] [Related]

  • 4. Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates.
    Albanese A, Granata R, Gregori B, Piccardi MP, Colosimo C, Tonali P.
    Neuroscience; 1993 Aug 03; 55(3):823-32. PubMed ID: 8105418
    [Abstract] [Full Text] [Related]

  • 5. Effects of L-deprenyl and amantadine in an MPTP-model of parkinsonism.
    Rausch WD, Schallauer E, Chan WW, Riederer P, Weiser M.
    J Neural Transm Suppl; 1990 Aug 03; 32():269-75. PubMed ID: 1708404
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxin.
    Ueki A, Chong PN, Albanese A, Rose S, Chivers JK, Jenner P, Marsden CD.
    Neuropharmacology; 1989 Oct 03; 28(10):1089-97. PubMed ID: 2510050
    [Abstract] [Full Text] [Related]

  • 9. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment.
    Elsworth JD, Taylor JR, Sladek JR, Collier TJ, Redmond DE, Roth RH.
    Neuroscience; 2000 Oct 03; 95(2):399-408. PubMed ID: 10658619
    [Abstract] [Full Text] [Related]

  • 10. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.
    Jenner P, Rupniak NM, Rose S, Kelly E, Kilpatrick G, Lees A, Marsden CD.
    Neurosci Lett; 1984 Sep 07; 50(1-3):85-90. PubMed ID: 6436758
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vivo changes of catecholamines in hemiparkinsonian monkeys measured by microdialysis.
    Skirboll S, Wang J, Mefford I, Hsiao J, Bankiewicz KS.
    Exp Neurol; 1990 Nov 07; 110(2):187-93. PubMed ID: 1699780
    [Abstract] [Full Text] [Related]

  • 13. Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment.
    Schneider JS, Pope A, Simpson K, Taggart J, Smith MG, DiStefano L.
    Science; 1992 May 08; 256(5058):843-6. PubMed ID: 1350379
    [Abstract] [Full Text] [Related]

  • 14. Neuropeptide levels in the basal ganglia of aged common marmosets following prolonged treatment with MPTP.
    Taylor MD, de Ceballos ML, Rose S, Chong PN, Jenner P, Marsden CD.
    J Neural Transm Park Dis Dement Sect; 1991 May 08; 3(2):99-108. PubMed ID: 1716907
    [Abstract] [Full Text] [Related]

  • 15. Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.
    Cohen G, Pasik P, Cohen B, Leist A, Mytilineou C, Yahr MD.
    Eur J Pharmacol; 1984 Oct 30; 106(1):209-10. PubMed ID: 6442232
    [No Abstract] [Full Text] [Related]

  • 16. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ, Whittington PE, Audsley AR.
    Brain Res; 1986 Dec 10; 399(2):339-45. PubMed ID: 2435361
    [Abstract] [Full Text] [Related]

  • 17. Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines in heart, adrenal gland, retina and caudate nucleus of the cat.
    Ambrosio S, Blesa R, Mintenig GM, Palacios-Araus L, Mahy N, Gual A.
    Toxicol Lett; 1988 Nov 10; 44(1-2):1-6. PubMed ID: 3263717
    [Abstract] [Full Text] [Related]

  • 18. Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset.
    Pérez-Otaño I, Herrero MT, Oset C, De Ceballos ML, Luquin MR, Obeso JA, Del Río J.
    Brain Res; 1991 Dec 13; 567(1):127-32. PubMed ID: 1815820
    [Abstract] [Full Text] [Related]

  • 19. Neurobehavioral protection by single dose l-deprenyl against MPTP-induced parkinsonism in common marmosets.
    Ando K, Maeda J, Inaji M, Okauchi T, Obayashi S, Higuchi M, Suhara T, Tanioka Y.
    Psychopharmacology (Berl); 2008 Jan 13; 195(4):509-16. PubMed ID: 17879087
    [Abstract] [Full Text] [Related]

  • 20. Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys.
    Falardeau P, Bouchard S, Bédard PJ, Boucher R, Di Paolo T.
    Eur J Pharmacol; 1988 May 20; 150(1-2):59-66. PubMed ID: 3261249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.